About CODAGENIX INC
Codagenix is a biotechnology company leveraging synthetic biology to develop live-attenuated vaccines with enhanced safety and scalability. The company focuses on infectious disease solutions through advanced viral genome editing.
synthetic biology platform developmentlive-attenuated virus designcodon deoptimization technologyviral genome editingoral polio vaccine development
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| CONDUCT A PHASE 2B EFFICACY STUDY AS PRESCRIBED IN AOI15 WITH COVILIV A PROPRIETARY LIVE ATTENUATED VIRUS COVI | Department of Health and Human Services | $10.0M | |
| Federal contract award | Department of Defense | $948K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CODAGENIX INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.